Tirzepatide Shows Promise for Obese Patients Undergoing TAVR Recent research indicates that tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, may significantly improve outcomes for …
Tag: